Results 101 to 110 of about 288,397 (260)

Genetic Reprogramming Following Nuclear Transplantation in Amphibia

open access: yes, 1999
GENETIC REPROGRAMMING FOLLOWING NUCLEAR TRANSPLANTATION IN AMPHIBIA Genetic Reprogramming Following Nuclear Transplantation in Amphibia (10) (-
Gurdon, J.B.
core   +1 more source

Diversity Control in Early Transcribed ROS/RNSbalancing Genes: A Common Mechanism for Healthy Resilience? [PDF]

open access: yesInnovations in Digital Health, Diagnostics, and Biomarkers, 2022
Birgit Arnholdt-Schmitt   +2 more
doaj   +1 more source

A systematic flux analysis approach to identify metabolic vulnerabilities in human breast cancer cell lines

open access: yesCancer & Metabolism, 2019
Background Increased flux through both glycolytic and oxidative metabolic pathways is a hallmark of breast cancer cells and is critical for their growth and survival.
Sheree D. Martin, Sean L. McGee
doaj   +1 more source

BCG vaccination potentiates oxidative phosphorylation in neonatal myeloid‐derived suppressor cells

open access: yesFEBS Open Bio, EarlyView.
BCG vaccination enhances oxidative phosphorylation in neonatal MDSCs, impairing their immunosuppressive function. It upregulates electron transport chain genes and mitochondrial activity, increasing ATP and oxygen consumption. Pharmacological OXPHOS inhibition partially restores suppressive capacity, confirming causality.
Yingying Chen, Hui Li
wiley   +1 more source

Cancer cell reprogramming conditions.

open access: yes, 2015
Cells positive for the live stain alkaline phosphatase (AP) cells were counted as indicators of cancer reprogramming. HT29 cells were transfected with miRs as indicated and grown in culture under several conditions (culture medium, MEF feeder cells, and ...
Hiroaki Nagano (282467)   +18 more
core   +1 more source

IGF2 knockout reduces but does not abolish osteosarcoma growth in vitro and in vivo

open access: yesFEBS Open Bio, EarlyView.
To test whether endogenous IGF2 promotes osteosarcoma growth, IGF2 was knocked out in Saos2 cells via CRISPR‐Cas9. KO cells showed reduced proliferation in vitro, and knockout xenografts in mice reached only ~25% of wild‐type tumor volume. Insulin‐like growth factor 2 (IGF2) is implicated in osteosarcoma, but direct functional evidence of its role is ...
Shun Yao, Marco Archetti
wiley   +1 more source

Correction: Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer

open access: yesJournal of Experimental & Clinical Cancer Research, 2023
Yonghao Zhan   +13 more
doaj   +1 more source

Chronobiology of Cancer: How Aging Fuels Oncogenesis at the Molecular Level

open access: yesAging and Cancer, EarlyView.
This graphical abstract illustrates the key biological pathways linking aging with cancer development and progression. In the upper left, cumulative exposure to ultraviolet radiation, toxins, and reactive oxygen species (ROS) causes DNA damage and genomic instability, whereas age‐related decline in repair mechanisms, such as ATM/ATR, BER, and NER ...
Anu Singh, Aroonima Misra, Sufian Zaheer
wiley   +1 more source

Transcription factors used for hepatic reprogramming.

open access: yes, 2014
11TF includes all genes.*Included in 6TF.Sufficient for hepatic reprogramming when combined with HNF1A.Necessary for hepatic reprogramming.
Kamen P. Simeonov (588591)   +1 more
core   +1 more source

Uncovering G Protein‐Coupled Receptors: Novel Targets and Biomarkers for Predicting Glioma Prognosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Low‐grade gliomas (LGG) exhibit significant heterogeneity and recurrence risk. G protein‐coupled receptors (GPCR) contribute to glioma malignant progression, but their prognostic value remains unclear. This work attempts to formulate a GPCR‐based outcome‐predicting model for LGG. Methods Based on TCGA LGG data, the enrichment scores
Jun Yang   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy